Skip to main navigation

About
- Company
- Leadership
- Laboratory
- Careers
Products
Applications
Technology
Resources
- News Center
- Conferences
- Library
- Blog
- Contact
Investors

Press Releases

Press Releases

Year

Aug 30, 2022

Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Aug 17, 2022

Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics

Aug 16, 2022

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 15, 2022

Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers

Aug 04, 2022

Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Aug 03, 2022

Personalis Reports Second Quarter 2022 Financial Results

Aug 02, 2022

Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics

Jul 20, 2022

Personalis to Announce Second Quarter 2022 Financial Results

Jul 12, 2022

Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease

May 04, 2022

Personalis Reports First Quarter 2022 Financial Results

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 26

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website

© 2022 Personalis Inc. All rights reserved.